Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any familial atrial fibrillation in which the cause of the disease is a mutation in the SCN2B gene.
Features include always present findings: ST segment elevation and Paroxysmal atrial fibrillation; and common findings: Hypertension and Prolonged PR interval.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Heart and blood vessels | 2 | Hypertension, Paroxysmal atrial fibrillation |
SCN2B function has not been fully characterized.
Atrial fibrillation, familial, 14 is associated with mutations in the SCN2B gene on chromosome 11.
Genetic testing for SCN2B is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for atrial fibrillation, familial, 14 has been reported in the published literature.
Phenotype severity distribution: 2 always present features, 2 common features.
No clinical trials have been registered for atrial fibrillation, familial, 14.
286 publications have been identified in PubMed for atrial fibrillation, familial, 14. Kisho has analyzed 73 by research type. Research spans Epidemiology / Natural History (47%), Clinical Trial Publication (32%), and Review / Meta-Analysis (11%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 34 | 47% |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 8:28 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Clinical study results |
23 |
32% |
Research summaries | 8 | 11% |
Laboratory research | 4 | 5% |
Testing and diagnosis research | 3 | 4% |
Patient case studies | 1 | 1% |
Hu X (2026). [PMID: 40221109](https://pubmed.ncbi.nlm.nih.gov/40221109/). *Heart Rhythm*. [Review / Meta-Analysis]
Cacciapuoti F (2026). [PMID: 41892842](https://pubmed.ncbi.nlm.nih.gov/41892842/). *Med Sci (Basel)*. [Review / Meta-Analysis]
Lu Y (2026). [PMID: 40921279](https://pubmed.ncbi.nlm.nih.gov/40921279/). *Int J Cardiol*. [Epidemiology / Natural History]
Zhang H (2025). [PMID: 40327545](https://pubmed.ncbi.nlm.nih.gov/40327545/). *Europace*. [Clinical Trial Publication]
Sultan D (2025). [PMID: 40498015](https://pubmed.ncbi.nlm.nih.gov/40498015/). *Cells*. [Review / Meta-Analysis]
Singer DE (2025). [PMID: 39297839](https://pubmed.ncbi.nlm.nih.gov/39297839/). *JACC Clin Electrophysiol*. [Clinical Trial Publication]
Qiao Y (2025). [PMID: 40281650](https://pubmed.ncbi.nlm.nih.gov/40281650/). *J Am Heart Assoc*. [Epidemiology / Natural History]
Gorczyca-Głowacka I (2025). [PMID: 40214237](https://pubmed.ncbi.nlm.nih.gov/40214237/). *Kardiol Pol*. [Epidemiology / Natural History]
Liu WT (2025). [PMID: 40611485](https://pubmed.ncbi.nlm.nih.gov/40611485/). *J Am Heart Assoc*. [Clinical Trial Publication]
Kishihara J (2025). [PMID: 39181488](https://pubmed.ncbi.nlm.nih.gov/39181488/). *Heart Rhythm*. [Clinical Trial Publication]